{
 "drug": "Cobicistat Tablet",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "10/07/2025",
 "dayN": 322,
 "cat": "Antiviral",
 "companies": [
  "Gilead Sciences, Inc."
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "10/07/2025",
   "update_type": "New",
   "initial_posting_date": "10/07/2025",
   "package_ndc": "61958-1401-1",
   "generic_name": "Cobicistat Tablet",
   "contact_info": "800-445-3235",
   "related_info": "Gilead plans to sell through the end of February 2026. Discontinuation of the manufacture of the drug due to business reasons.",
   "openfda": {
    "application_number": [
     "NDA203094"
    ],
    "brand_name": [
     "TYBOST"
    ],
    "generic_name": [
     "COBICISTAT"
    ],
    "manufacturer_name": [
     "Gilead Sciences, Inc."
    ],
    "product_ndc": [
     "61958-1401",
     "61958-1402"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "COBICISTAT"
    ],
    "rxcui": [
     "1551993",
     "1551999",
     "2719618",
     "2719620"
    ],
    "spl_id": [
     "169d8571-3b28-4b3b-8def-18316f1297f3"
    ],
    "spl_set_id": [
     "3784c35c-e87f-410c-900b-8fd6313c6010"
    ],
    "package_ndc": [
     "61958-1401-1",
     "61958-1402-1"
    ],
    "nui": [
     "N0000190114",
     "N0000191001",
     "N0000185503",
     "N0000182137",
     "N0000190107",
     "N0000190108",
     "N0000190113",
     "N0000191423"
    ],
    "pharm_class_moa": [
     "Cytochrome P450 3A Inhibitors [MoA]",
     "P-Glycoprotein Inhibitors [MoA]",
     "Cytochrome P450 2D6 Inhibitors [MoA]",
     "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
     "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
     "Breast Cancer Resistance Protein Inhibitors [MoA]",
     "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]"
    ],
    "pharm_class_epc": [
     "Cytochrome P450 3A Inhibitor [EPC]"
    ],
    "unii": [
     "LW2E03M5PG"
    ]
   },
   "update_date": "10/07/2025",
   "therapeutic_category": [
    "Antiviral"
   ],
   "dosage_form": "Tablet",
   "presentation": "Tybost, Tablet, 150 mg (NDC 61958-1401-1)",
   "company_name": "Gilead Sciences, Inc.",
   "status": "To Be Discontinued"
  }
 ]
}